Brief: Xbrane Biopharma, AGC Biologics Enter Into Agreement To Manufacture Xcimzane
07/10/2021 07:05
Oct 7 (Reuters) - Xbrane Biopharma AB XBRANE.ST :
* XBRANE BIOPHARMA AND AGC BIOLOGICS ENTER INTO AN AGREEMENT
TO
MANUFACTURE XCIMZANE™ FOR CLINICAL DEVELOPMENT
* UNDER TERMS OF AGREEMENT, COMPANIES WILL WORK TOGETHER TO
UPSCALE ESTABLISHED XCIMZANETM MANUFACTURING PROCESS AND PRODUCE
SEVERAL COMMERCIAL SCALE BATCHES FOR UPCOMING PHASE I AND PHASE
III CLINICAL TRIALS
Source text for Eikon: ID:nMFN36nFRX
Further company coverage: XBRANE.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))